Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,675 JPY | +0.55% | +3.67% | +1.66% |
2023 | Dalton Submits Shareholder Proposal to Hogy Medical | CI |
2022 | Tranche Update on Hogy Medical Co.,Ltd.'s Equity Buyback Plan announced on February 8, 2022. | CI |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company appears to be poorly valued given its net asset value.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.18 times its estimated earnings per share for the ongoing year.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.66% | 567M | - | ||
+11.84% | 27.79B | B+ | ||
-32.59% | 2.98B | B- | ||
-15.97% | 2.52B | C+ | ||
+11.90% | 2.34B | - | A- | |
-1.11% | 1.91B | B | ||
-7.78% | 1.39B | B | ||
-0.38% | 1.27B | - | ||
+6.01% | 1.13B | - | ||
+13.51% | 1.12B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3593 Stock
- Ratings Hogy Medical Co.,Ltd.